The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Complement and Its Receptors: New Insights into Human Disease
Open accessAbstract
Although new activation and regulatory mechanisms are still being identified, the basic architecture of the complement system has been known for decades. Two major roles of complement are to control certain bacterial infections and to promote clearance of apoptotic cells. In addition, although inappropriate complement activation has long been proposed to cause tissue damage in human inflammatory and autoimmune diseases, whether this is indeed true has been uncertain. However, recent studies in humans, especially those using newly available biological therapeutics, have now clearly demonstrated the pathophysiologic importance of the complement system in several rare diseases. Beyond these conditions, recent genetic studies have strongly supported an injurious role for complement in a wide array of human inflammatory, degenerative, and autoimmune diseases. This review includes an overview of complement activation, regulatory, and effector mechanisms. It then focuses on new understandings gained from genetic studies, ex vivo analyses, therapeutic trials, and animal models as well as on new research opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional inducers of low-grade inflammation are nutrients and metabolites acting as DAMPs (e.g., free fatty acids, oxidized lipoproteins) and commensal bacteria representing a source of PAMPs [sometimes also described with the more global term microbe-associated molecular patterns (MAMPs), as they are not necessarily pathogenic] (189, 240, 244, 295, 329, 347).”
From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [240]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654 · cited 3×
“Additionally, the recently recognized roles of complement in homeostasis point to several nontraditional functions that bridge immunity and developmental biology (12).”
BackgroundInfluentialEvolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,653
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
The Instructive Role of Innate Immunity in the Acquired Immune Response
Fearon, D. T., & Locksley, R. M. (1996) · Science · doi:10.1126/science.272.5258.50 · Cited by 1,711
C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
Dempsey, P. W., Allison, M. E. D., Akkaraju, S., Goodnow, C. C., & Fearon, D. T. (1996) · Science · doi:10.1126/science.271.5247.348 · Cited by 1,197
Generation of C5a in the absence of C3: a new complement activation pathway
Huber-Lang, M. S., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., et al. (2006) · Nature Medicine · doi:10.1038/nm1419 · Cited by 976
MOLECULAR ORGANIZATION AND FUNCTION OF THE COMPLEMENT SYSTEM
Müller‐Eberhard, H. J. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001541 · Cited by 856
Rother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., & Bell, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1344 · Cited by 778 · cited 2×
“On red blood cells, the absence of DAF allows alternative pathway–initiated complement activation by C3 and C5 convertases; the absence of CD59 allows activated C5 to proceed to form the MAC, resulting in intravascular hemolysis (102, 103).”
BackgroundModulation of the antitumor immune response by complement
Markiewski, M. M., DeAngelis, R. A., Benencia, F., Ricklin-Lichtsteiner, S. K., Koutoulaki, A., Gerard, C. J., Coukos, G., & Lambris, J. D. (2008) · Nature Immunology · doi:10.1038/ni.1655 · Cited by 770
Molecular Intercommunication between the Complement and Coagulation Systems
Amara, U., Flierl, M. A., Rittirsch, D., Klos, A., Chen, H., Acker, B., Brückner, U. B., Nilsson, B., Gebhard, F. T., Lambris, J. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903678 · Cited by 719
Research works printed but not linked: 6
- Holers VM, 1989, Year Immunol., 4, 231
- Song JJ, 2011, J. Clin. Investig., 121, 3517
- Rose KL, 2008, J. Clin. Investig., 118, 608
- Calero I, 2010, Discov. Med., 10, 416
- He S, 2009, J. Clin. Investig., 119, 2304
- Thurman JM, J. Clin. Investig., 123, 2103
Cited by
Sorted by citations
Items 201–300 of 430
Genetic and molecular evidence for complement dysregulation in patients with HELLP syndrome
Bazzan, M., Todros, T., Tedeschi, S., Ardissino, G., Cardaropoli, S., Stella, S., Montaruli, B., Marchese, C. A., Roccatello, D., & Cugno, M. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.08.038 · Cited by 17
Mishra, R., Behera, L. M., & Rana, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1820381 · Cited by 17
Oral streptococci show diversity in resistance to complement immunity
Alves, L. A., de Carli, T. R., Harth-Chú, É. N., Mariano, F. S., Höfling, J. F., Stipp, R. N., & Mattos‐Graner, R. O. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000955 · Cited by 16
Regulation of B cell functions by Toll-like receptors and complement
Kremlitzka, M., Mácsik‐Valent, B., & Erdei, A. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.07.015 · Cited by 16
Complement and systemic lupus erythematosus
Liu, C., Manzi, S., & Ahearn, J. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93232-5.00026-5 · Cited by 16
Structure and function of therapeutic antibodies approved by the US FDA in 2024
Strohl, W. R. (2025) · Antibody Therapeutics · doi:10.1093/abt/tbaf014 · Cited by 16
Gao, M., Dong, Q., Lu, Y., Yao, H., Zou, M., Yang, Y., Zhu, J., Yang, Z., Xu, M., & Xu, R. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0172-7 · Cited by 15
McCulloch, L. J., Allan, S. M., Emsley, H. C. A., Smith, C. J., & McColl, B. W. (2019) · F1000Research · doi:10.12688/f1000research.19308.2 · Cited by 17
Vardi, A., Ben‐Dor, S., Cho, S. M., Kalinke, U., Spanier, J., & Futerman, A. H. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01934-x · Cited by 15
Shen, J., Xiang, S., Peng, M., Zhou, Z., & Wu, Z. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.02092 · Cited by 14
Complement Inhibition for Geographic Atrophy: A Tempting Target with Mixed Results
Lin, J. B., Halawa, O. A., Miller, J. W., & Vavvas, D. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132890 · Cited by 14
Uher, O., Huynh, T., Zhu, B., Horn, L. A., Caisová, V., Vanova, K. H., Medina, R., Wang, H., Palena, C., Chmelař, J., et al. (2021) · Cancers · doi:10.3390/cancers13163942 · Cited by 14
Fungal Reproduction and Growth
Sultan, S., & Singh, G. K. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95215 · Cited by 14
An overview of quantum dots-induced immunotoxicity and the underlying mechanisms
Wei, T., Zhang, T., & Tang, M. X. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.119865 · Cited by 15
IVIG efficacy in CIDP patients is not associated with terminal complement inhibition
Keller, C. W., Quast, I., Dalakas, M. C., & Lünemann, J. D. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.02.001 · Cited by 14
Humanized C3 Mouse: A Novel Accelerated Model of C3 Glomerulopathy
Devalaraja-Narashimha, K. B., Meagher, K. A., Luo, Y., Huang, C., Kaplan, T. J., Muthuswamy, A., Halász, G., Casanova, S., O’Brien, J., Boiarsky, R. P., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020050698 · Cited by 14
Diep, N. T., Giang, N. T., Diu, N. T. T., Nam, N. M., Khanh, L. V., Quang, H. V., Hang, N. T., Mão, C. V., Son, H. V., Hieu, N. L., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-44512-w · Cited by 13
Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg
Wang, Y., Lai, P., Chen, X., He, C., Huang, X., Geng, S., Luo, C., Wu, S., Wei, L., Zhong, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03700-1 · Cited by 13
Tallmadge, R. L., Wang, M., Sun, Q., & Felippe, M. J. B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202646 · Cited by 13
Green, M. S., Schwartz, N., & Peer, V. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820002356 · Cited by 15
Pulmonary vascular system: A vulnerable target for COVID‐19
Ai, J., Hong, W., Wu, M., & Wei, X. (2021) · MedComm · doi:10.1002/mco2.94 · Cited by 13
Wang, Q., Wang, Q., Zhao, Z., Fan, J., Qin, L., Alexander, D. B., Tsuda, H., Zhao, D., & Xu, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.758941 · Cited by 16
Fahnoe, K. C., Liu, F., Morgan, J. G., Ryan, S. T., Storek, M., Stark, E. G., Taylor, F. R., Holers, V. M., Thurman, J. M., Wawersik, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869725 · Cited by 13
Self-citationFactor H C-Terminal Domains Are Critical for Regulation of Platelet/Granulocyte Aggregate Formation
Blatt, A. Z., Saggu, G., Cortés, C., Herbert, A. P., Kavanagh, D., Ricklin, D., Lambris, J. D., & Ferreira, V. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01586 · Cited by 13
Immunological Considerations for Retinal Stem Cell Therapy
Kramer, J., Chirco, K. R., & Lamba, D. A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-28471-8_4 · Cited by 13
Hammad, R., Hamdino, M., El-Nasser, A. M., Sobhy, A., Eldesoky, N. A.-R., Mashaal, A., & Ali, H. F. (2020) · Innate Immunity · doi:10.1177/1753425920942570 · Cited by 13
Complement regulation in tumor immune evasion
Liu, G., He, X., Zhao, G., & Lu, Z. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101912 · Cited by 13
A study of multinucleated giant cells in esophageal cancer
Wang, H., Zhou, J., Li, J., Geng, Y., Meng, P., Ma, C., Zhu, Z., Zhang, W., Hong, L., Quan, Y., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108600 · Cited by 12
Kuboi, Y., Suzuki, Y., Motoi, S., Matsui, C., Toritsuka, N., Nakatani, T., Tahara, K., Takahashi, Y., Ida, Y., Tomimatsu, A., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.01.005 · Cited by 12
Francisella tularensis Confronts the Complement System
Brock, S. R., & Parmely, M. J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00523 · Cited by 12
Olutogun, T., Cutini, I., Notaro, R., & Luzzatto, L. (2015) · PubMed Central · doi:10.2450/2015.0249-14 · Cited by 12
Pathogenesis of Osteoarthritis in General
Goldring, M. B., Culley, K. L., & Otero, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-45803-8_1 · Cited by 12
Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease
Sandri, T. L., Lidani, K. C. F., Andrade, F. A., Meyer, C. G., Kremsner, P. G., Messias-Reason, I., & Velavan, T. P. (2018) · Scientific Reports · doi:10.1038/s41598-017-18937-z · Cited by 12
The Complement System: A Potential Therapeutic Target in Liver Cancer
Yuan, M., Liu, L., Wang, C., Zhang, Y., & Zhang, J. (2022) · Life · doi:10.3390/life12101532 · Cited by 12
A group of serum proteins as potential diagnostic biomarkers for Yin‐deficiency‐heat syndrome
Chen, J., Jiang, T., Yi, W., Jiao, J., Liu, C., Tu, H., Hu, Y., Shi, L., Huang, H., Li, Z., et al. (2020) · The Anatomical Record · doi:10.1002/ar.24351 · Cited by 11
Lage, S. L., Wong, C.-S., Amaral, E. P., Sturdevant, D. E., Hsu, D. C., Rupert, A. W., Wilson, E. M. P., Qasba, S. S., Naqvi, N., Laidlaw, E., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009435 · Cited by 11
Ren, J., Chen, L., Chen, X., Zhang, N., Sun, X., & Song, J. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14218 · Cited by 11
Gao, M., Dong, Q., Yao, H., Lu, Y., Ji, X., Zou, M., Yang, Z., Xu, M., & Xu, R. (2017) · Scientific Reports · doi:10.1038/srep45989 · Cited by 11
Low prevalence of rheumatoid arthritis among patients with pre-existing type 2 diabetes mellitus
Tentolouris, A., Thanopoulou, A. C., Tentolouris, N., Eleftheriadou, I., Voulgari, C., Andrianakos, A., & Sfikakis, P. P. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.09.14 · Cited by 11
Retroviruses, immunosuppression and osteopetrosis.
Labat, M. L. (1986) · PubMed · Cited by 11
Complement-related molecular classification and a gene signature for lung adenocarcinoma
Zhang, L., Yang, Y., Lin, W., Shao, F., Gao, Y., & He, J. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00388-0 · Cited by 10
Augusto‐Oliveira, M., Tremblay, M., & Verkhratsky, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_6 · Cited by 10
Yuan, H. D., Du, L., & Ge, P. (2020) · Bioscience Reports · doi:10.1042/bsr20200321 · Cited by 11
Proteomic Profiling Reveals the Molecular Changes of Insomnia Patients
Wang, G., Ren, X., Zhang, X., Wang, Q., Liu, T., Deng, N., & Yan, D. (2021) · BioMed Research International · doi:10.1155/2021/6685929 · Cited by 10
Li, Z., Zhang, W., Gao, F., Tang, Q., Kang, D., & Shen, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.810335 · Cited by 10
Antiviral Innate Immunity: Introduction☆
Weber, F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02608-8 · Cited by 10
Ding, P., Li, L., Huang, T.-B., Yang, C., Xu, E., Wang, N., Zhang, L., Gu, H., Yao, X., Zhou, X., et al. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.05.014 · Cited by 10
Geographical distribution of complement receptor type 1 variants and their associated disease risk
Sandri, T. L., Adukpo, S., Giang, D. P., Nguetse, C. N., Andrade, F. A., Tong, H. V., Toàn, N. L., Le, S. H., Elumalai, P., Kumarasamy Thangaraj, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175973 · Cited by 10
Panwar, H. S., Ojha, H., Ghosh, P., Barage, S. H., Raut, S., & Sahu, A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818573116 · Cited by 10
Artesunate: A natural product-based immunomodulator involved in human complement
Song, L., Ge, T., Li, Z., Sun, J., Li, G., Sun, Y., Fang, L., Ma, Y. J., & Garred, P. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111234 · Cited by 10
A Metabolic Gene Signature to Predict Breast Cancer Prognosis
Lu, J., Liu, P., & Zhang, R. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.900433 · Cited by 10
Exosomal‐complement system activation in preeclampsia
David, M., Maharaj, N. R., & Anand, K. (2025) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16255 · Cited by 10
The complement cascade in Alzheimer’s disease: modern implications of an ancient immune protagonist
Papavergi, M.-T., Bathini, P., Singh, B. B., & Lemere, C. A. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00916-y · Cited by 12
Önengüt-Gümüşcü, S., Webb‐Robertson, B., Sarkar, S., Manichaikul, A. W., Hu, X., Frazer‐Abel, A. A., Holers, V. M., Rewers, M., & Rich, S. S. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3716 · Cited by 8
Self-citationElectrostatic Steering Accelerates C3d:CR2 Association
Mohan, R. R., Huber, G., & Morikis, D. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b02095 · Cited by 9
Leukotriene B4 and Its Receptor in Experimental Autoimmune Uveitis and in Human Retinal Tissues
Eskandarpour, M., Chen, Y., Nunn, M. A., Coupland, S. E., Weston‐Davies, W., & Calder, V. L. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.10.010 · Cited by 9
Gao, M., Dong, Q., Wang, W., Yang, Z., Guo, L., Lu, Y., Ding, B., Chen, L., Zhang, J., & Xu, R. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02186-z · Cited by 9
The role of properdin and Factor H in disease
Cortés, C., Desler, C., Mazzoli, A., Chen, J. Y., & Ferreira, V. P. (2022) · Advances in immunology · doi:10.1016/bs.ai.2021.12.001 · Cited by 10
García-González, M., Gómez-Bernal, F., Quevedo-Abeledo, J. C., Fernández-Cladera, Y., González-Rivero, A. F., de Vera-González, A., Rua-Figueroa, I., López‐Mejías, R., Díaz‐González, F., González-Gay, M. Á., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1167055 · Cited by 9
Chemical Approaches to Modulating Complement-Mediated Diseases
Iyer, A., Xu, W., Reid, R. C., & Fairlie, D. P. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00882 · Cited by 9
Complement system activation and peritoneal membrane alterations: Culprit or innocent bystander?
Borceux, P., Morelle, J., & Goffin, E. J. (2020) · Peritoneal Dialysis International · doi:10.1177/0896860819896242 · Cited by 9
Bélot, A., Tusseau, M., Cognard, J., Georgin‐Lavialle, S., Boursier, G., & Hedrich, C. M. (2025) · ACR Open Rheumatology · doi:10.1002/acr2.70003 · Cited by 8
de Walle, I. V., Bracke, L., Olesen, H. G., Bragt, T. V., Cadour, S., Decker, P. D., Ciurlia, G., Pannecoucke, E., Persson, E. K., de Steen, O. V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62925-1 · Cited by 8
Role of Complement Receptors (CRs) on DCs in Anti-HIV-1 Immunity
Posch, W., Bermejo‐Jambrina, M., Lass‐Flörl, C., & Wilflingseder, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572114 · Cited by 9
Cheng, J., Clayton, J. S., Acemel, R. D., Zheng, Y., Taylor, R. L., Keleş, S., Franke, M., Boackle, S. A., Harley, J. B., Quail, E. A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.901747 · Cited by 8
Redox Events As Modulators of Pathology and Therapy of Neuroinflammatory Diseases
Lepka, K., Berndt, C., Hartung, H., & Aktaş, O. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00063 · Cited by 8
Ramlall, V., Thangara, P. M., Tatonetti, N. P., & Shapira, S. D. (2020) · doi:10.21203/rs.3.rs-26451/v1 · Cited by 8
Rodríguez-González, D., García-González, M., Gómez-Bernal, F., Quevedo-Abeledo, J. C., González-Rivero, A. F., Fernández-Cladera, Y., González-López, E., Ocejo-Vinyals, J. G., Jiménez, A., González-Toledo, B., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158360 · Cited by 10
Zipfel, P. F., & Heidenreich, K. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf065 · Cited by 7
Jia, Z., Yu, W., Li, J., Zhang, M., Zhan, B., Yan, L., Ming, Z., Cheng, Y., Tian, X., Shao, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1404752 · Cited by 7
Magnusen, A. F., & Pandey, M. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212252 · Cited by 9
Isenman, D. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810420-0.00017-1 · Cited by 7
Complement Activation by Nanomaterials
Simberg, D., & Moghimi, S. M. (2020) · Molecular and integrative toxicology · doi:10.1007/978-3-030-33962-3_6 · Cited by 7
Identification of Sex-Specific Genetic Variants Associated With Tau PET
Wang, X., Broce, I., Deters, K., Fan, C. C., & Banks, S. J. (2022) · Neurology Genetics · doi:10.1212/nxg.0000000000200043 · Cited by 7
Echinococcus multilocularis Calreticulin Interferes with C1q-Mediated Complement Activation
Xian, S., Chen, L., Yan, Y., Chen, J., Yu, G., Shao, Y., Zhan, B., Wang, Y., & Zhao, L. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8010047 · Cited by 7
Pathogenesis of Lupus Nephritis
Fu, S. M., Sung, S. J., Wang, H., & Gaskin, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00020-7 · Cited by 7
Innate and Adaptive Systems of Immunity
Delves, P. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00004-x · Cited by 7
Fernández-Cladera, Y., García-González, M., Hernández-Díaz, M., Gómez-Bernal, F., Quevedo-Abeledo, J. C., González-Rivero, A. F., de Vera-González, A., Gómez‐Moreno, C., González-Gay, M. Á., & Ferraz‐Amaro, I. (2024) · Biomedicines · doi:10.3390/biomedicines12050967 · Cited by 6
Dinice, L., Cosimi, P., Esposito, G., Scarinci, F., Cacciamani, A., Cafiero, C., Placentino, L., Ripandelli, G., & Micera, A. (2025) · Antioxidants · doi:10.3390/antiox14070841 · Cited by 6
Zhu, X., Zhang, L., & Qi, S. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i5.2168 · Cited by 7
Almuraikhy, S., Ramanjaneya, M., Dömling, A. S. S., Bettahi, I., Donati, F., Botrè, F., Abou‐Samra, A., Sellami, M., & Elrayess, M. A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.715035 · Cited by 6
Complement component C1q is an immunological rheostat that regulates Fc:Fc$$\gamma$$R interactions
So, E. C., Zhou, H., Greenwell, A., Burch, E. E., Ji, Y., Mérigeon, E. Y., Olsen, H. S., Bentzen, S. M., Block, D. S., Zhang, X., et al. (2023) · Immunogenetics · doi:10.1007/s00251-023-01311-x · Cited by 6
Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid
Lee, M., Wathier, M., Love, J. A., McGeer, E. G., & McGeer, P. L. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.018 · Cited by 6
Dichotomy of complement system: Tumorigenesis or destruction
Sinha, A., Singh, V. K., Tandon, R., & Srivastava, L. M. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.04.013 · Cited by 6
Lynch, A. M., Grove, N. C., Wagner, B. D., Palestine, A. G., Holers, V. M., Frazer‐Abel, A. A., Gnanaraj, R., Lisker-Cervantes, A., Patnaik, J. L., de Carlo, T. E., et al. (2025) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2025.1608 · Cited by 5
Self-citationC4d, a high-affinity LilrB2 ligand, is elevated in Alzheimer’s disease and mediates synapse pruning
Brott, B. K., Raissi, A. J., Micheva, K. D., Vielmetter, J., Mendes, M. S., Baccus, C. J., Huang, J., & Shatz, C. J. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2519253122 · Cited by 6
SKY59, A Novel Recycling Antibody for Complement-mediated Diseases
Fukuzawa, T., & Nezu, J. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191016115853 · Cited by 5
Mobini, M., Ghasemian, R., Larijani, L. V., Mataji, M., & Maleki, I. (2021) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_923_20 · Cited by 5
Todorova, B., Godon, O., Conde, E., Gillis, C. M., Iannascoli, B., Goff, O. R.-L., Fiole, D., Roumenina, L. T., Leusen, J. H. W., Murphy, A. J., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200234 · Cited by 5
Determining the Spatial Relationship of Membrane-Bound Aquaporin-4 Autoantibodies by STED Nanoscopy
Soltys, J. N., Meyer, S. A., Schumann, H., Gibson, E. A., Restrepo, D., & Bennett, J. L. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.03.012 · Cited by 5
Monedero, M., Infantes‐Lorenzo, J. A., Moreno, I., Algíbez, A. M., Macı́as, R. I. R., Toraño, A., & Domínguez, M. (2018) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2018.11.008 · Cited by 5
Porter, J. M., Oswald, M. S., Sharma, A., Emmanuel, S., Kansol, A., Bennett, A., McKenna, R., & Smith, J. G. (2023) · Journal of Virology · doi:10.1128/jvi.00060-23 · Cited by 7
The pattern recognition molecule collectin-L1 in critically ill children
Ingels, C., Vanhorebeek, I., Derese, I., Jensen, L., Wouters, P. J., Thiel, S., & den Berghe, G. V. (2016) · Pediatric Research · doi:10.1038/pr.2016.76 · Cited by 5
Complement Receptors in Myeloid Cell Adhesion and Phagocytosis
Dustin, M. L. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch23 · Cited by 5
Filho, M. M., Aguiar, P. N., Adashek, J. J., & de Mello, R. A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.02.21 · Cited by 5
Preclinical autophagy modulatory nanomedicines: big challenges, slow advances
Romero, E. L., & Morilla, M. J. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1933428 · Cited by 4
Liu, W., Zhu, X., & Xiao, Y. (2024) · Annals of Hematology · doi:10.1007/s00277-024-05798-6 · Cited by 4
Zoonotic and Zooanthroponotic Potential of Monkeypox
Atasoy, M. O., Naggar, R. F. E., Rohaim, M. A., & Munir, M. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-57165-7_5 · Cited by 4
Zhang, X., Zheng, J., Zhang, L., Zhang, J., Feng, L., Zhang, L., & Huang, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-00507-3 · Cited by 4
Kang, N., Wang, B., Li, Y., & Zhu, R. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104024 · Cited by 4
Metadata
- Authors
- Holers, V. M.
- Affiliations
- University of Colorado Anschutz (US)
- Corresponding author
- Holers, V. Michael
- ORCID
- Holers, V. Michael
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2014-03-21
- Volume
- 32
- Issue
- 1
- Pages
- 433-459
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2163243965
- Cited by
- 430
- References
- 152
- Citations by year
- 2026: 21 · 2025: 25 · 2024: 33 · 2023: 27 · 2022: 39 · 2021: 48 · 2020: 46 · 2019: 42 · 2018: 34 · 2017: 40 · 2016: 36 · 2015: 27 · 2014: 10
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Lupus Research Alliance
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R21AI105717)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR051749)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Keywords
- complement system, complement receptors, complement activation, complement regulation, efferocytosis, bacterial infection, inflammatory diseases, autoimmune disease, degenerative diseases, rare diseases, genetic research, complement therapeutics, tissue damage
- MeSH terms
- Animals, Carrier Proteins, Complement System Proteins, Complement Activation, Disease Models, Animal, Disease Susceptibility, Humans, Protein Binding, Receptors, Complement, Signal Transduction, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review